Morser J, Meager A, Burke D C, Secher D S
J Gen Virol. 1981 Apr;53(Pt 2):257-65. doi: 10.1099/0022-1317-53-2-257.
Mice and rats were immunized with human lymphoblastoid interferon, a mixture of human leukocyte (interferon-alpha) and human fibroblast (interferon-beta) interferons, and their serum anti-interferon levels measured. Anti-interferon activity was detected in all animals, although the mouse sera had higher titers than the rat sera. The spleens of two mice were removed and used to prepare hybrid myelomas. Anti-interferon activity in tissue culture supernatants was measured using a direct neutralization assay and a clone (NK2) producing antibody to human interferon-alpha (leukocyte) was isolated. The anti-interferon activity of this monoclonal antibody was confirmed using a new indirect immunoprecipitation (IIP) assay, which shows some advantages over the direct neutralization assay. The antibody did not neutralize human interferon-beta (fibroblast) or mouse interferon.
用人类淋巴母细胞干扰素(一种人类白细胞干扰素-α和人类成纤维细胞干扰素-β的混合物)对小鼠和大鼠进行免疫,并检测它们血清中的抗干扰素水平。在所有动物中均检测到抗干扰素活性,不过小鼠血清的效价比大鼠血清更高。取两只小鼠的脾脏用于制备杂交骨髓瘤。使用直接中和试验测量组织培养上清液中的抗干扰素活性,并分离出一株产生抗人类干扰素-α(白细胞)抗体的克隆(NK2)。使用一种新的间接免疫沉淀(IIP)试验证实了这种单克隆抗体的抗干扰素活性,该试验相对于直接中和试验具有一些优势。该抗体不能中和人类干扰素-β(成纤维细胞)或小鼠干扰素。